Osborne Clarke advised King’s College London on the deal. King’s College London established with ValiRx PLC (“ValiRx”) of Cytolytix Limited (“Cytolytix), a new ValiRx subsidiary formed...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here